Clinical characteristics of patients treated for velopharyngeal insufficiency
| Characteristics | |
|---|---|
| No. of patients | 15 |
| Mean age (SD) (yr) | 21.3 (21.9) |
| Median age (yr) (minimum, maximum) | 10 (3, 68) |
| No. (%) female | 8 (53.3) |
| Comorbidities (No.) (%) | |
| Velocardiofacial syndrome | 3 (20.0) |
| Neurofibromatosis type 1 | 3 (20.0) |
| Postsurgical complication | 3 (20.0) |
| Collet-Sicard syndrome | 1 (6.7) |
| Pierre-Robin sequence | 1 (6.7) |
| Oculopharyngeal muscular dystrophy | 1 (6.7) |
| Chiari II | 1 (6.7) |
| Cleft palate | 1 (6.7) |
| Sensorineural hearing loss | 1 (6.7) |
| Injection agent | |
| No. dextranomer/hyaluronic acid copolymer (%) | 14 (93.3) |
| No. hyaluronic acid (%) | 1 (6.7) |
| Mean (SD) volume of implant injected (mL) | 3.2 ± 1.2 |